
Medical Oncologist Hospital Sírio-Libanês Brasília-DF. Co-Chair GU @LACOG_group. News editor @MOCBrasil. Former fellow GU oncology @sloan_kettering.
Brasília-DF
Joined March 2009
- Tweets338
- Following745
- Followers715
- Likes3.1K
🌎 Global inequity in oncology is structural.
📏 Measuring the gap is the first step toward closing it.
📄 Our study provides evidence to inform policies for a more equitable and representative oncology community.
Only 1% of #ASCOGU faculty were LATAM-affiliated, despite co-authoring 53 oral presentations 🔎
#LATAM does the research. Others present it.
great work @drdanielvargas & team
Structural inequity, not lack of merit👇 @LACOG_group @OncoAlert
@JCOGO_ASCO bit.ly/4vOQTEr
Daniel Vargas Pivato de Almeida retweeted
Only 1% of #ASCOGU faculty were LATAM-affiliated, despite co-authoring 53 oral presentations 🔎
#LATAM does the research. Others present it.
great work @drdanielvargas & team
Structural inequity, not lack of merit👇 @LACOG_group @OncoAlert
@JCOGO_ASCO bit.ly/4vOQTEr
Thrilled to be part of this incredible team!
The LACOG GU group has evolved significantly in recent years as a natural result of the important achievements made by our investigators and administrative staff.
We are pleased to announce the Brazil and LATAM Board members of the LACOG Genitourinary Group.
This new board term will run from 2025 to 2027, with a continued focus on the development of innovative clinical and epidemiological studies.
#LACOG
#CancerResearch
Daniel Vargas Pivato de Almeida retweeted
Regime combinado perioperatório é aprovado pelo FDA para câncer de bexiga músculo-invasivo
Fase 3 KN905/EV-303: enfortumabe + pembrolizumabe perioperatório aumentou SLE e SG no MIBC inelegível ou com recusa à QT cisplatina
@drdanielvargas @FabioSchutz78
mocbrasil.com/blog/noticias/…
Daniel Vargas Pivato de Almeida retweeted
Excellent talk by @Ric_Campi on adjuvant RCC setting with thoughtful comments on multi-D strategy & shared decision making! @OncoAlert @mirrorsmed @b_szabados @Uromigos @mtsiatas @MichalisLiontos @spsutkaMD @EvanHallMD @drdanielvargas @cdanicas @PavlosMsaouel @LauraBukavinaMD
Daniel Vargas Pivato de Almeida retweeted
GU Review 2025 | 27–29 nov | São Paulo + online.
Actualización clave en tumores genitourinarios con referentes internacionales.
Acceso libre a la transmision virtual
geniturinariobrasil.com.br/e…
@LACOG_group @aaoncoclinica @ASCO @Marco_Care_AI @UroTarget @Blatam_urology
Sharing this excellent initiative led by my friends @fedelosco @mflazzaro_gu and others!
Sad for not being able to join in person!
🎯 #UroTarget cumple 10 años. Lo que nació como una reunión es hoy una comunidad y una forma de cuidar.
Gracias @mflazzaro_gu 💙 #Oncología #UroOncología
@aaoncoclinica @ASCO @Blatam_urology
Daniel Vargas Pivato de Almeida retweeted
ESMO 2025: Câncer de próstata | Dr. Daniel Vargas
Assista os destaques da #ESMO25 na área de Câncer de próstata, com apresentação do Dr. Daniel Vargas
e participação do Dr. Fabio Schutz
#MOCnaESMO #prostatecancer @drdanielvargas @FabioSchutz78
mocbrasil.com/blog/cobertura…
Daniel Vargas Pivato de Almeida retweeted
ESMO 2025: Câncer de Rim e Bexiga | Dr Daniel Vargas
Nesta aula, Dr Daniel Vargas apresenta os destaques de Câncer de Rim e Bexiga da #ESMO25, com posterior discussão clínica com Dr Fabio Schutz. Não perca!
#MOCnaESMO @drdanielvargas @FabioSchutz78
mocbrasil.com/blog/cobertura…
Daniel Vargas Pivato de Almeida retweeted
‼️Just Out at @JAMAOnc our Ph2 trial showing the efficacy of ICI with Chemotherapy in advanced PSCC.
Pembrolizumab Plus Platinum Chemotherapy in Advanced Penile Cancer jamanetwork.com/journals/jam…
Daniel Vargas Pivato de Almeida retweeted
Thank you @PGrivasMDPhD for spending such a fantastic time with our group in #Brasília!
We’re deeply honored to have you with us at this unforgettable dinner. #BladderCancer
@drdanielvargas @oncoclinicas (and @crisbergerot photobombing in the corner😂)
Daniel Vargas Pivato de Almeida retweeted
ASCO 2025: Câncer de próstata | Dr Daniel Vargas
Fique por dentro dos highlights da #ASCO25 em Câncer de próstata, com apresentação dos destaques pelo Dr Daniel Vargas e moderação do Dr Fernando Maluf
#MOCnaASCO @drdanielvargas @FabioSchutz78
mocbrasil.com/blog/asco-2025…
During the last #ASCO25 session on Prostate Cancer, presentation of updated data on #IronMan trial w/ our Brazilian PI @DrAndreFay. Last day only for the brave ones!
@LACOG_group @IRONMANregistry
Once again meeting the @LACOG_group board members and affiliates during the @ASCO meeting. We ahead the opportunity to renew our brand mark and resilience to develop research projects in the region!
Fantastic work by @PauloBergerot exploring this very important topic in LatAm.
Our study reveals stark disparities in exercise referrals in LATAM
Oncologists in public 🏥 are less likely to assess, refer or guide pts on exercise due to limited resources&training
See you there! #ASCO25
@crisbergerot @fitaftercancer @GlopesMd @EnriqueSoto8 @NarjustFlorezMD
Daniel Vargas Pivato de Almeida retweeted
Our study reveals stark disparities in exercise referrals in LATAM
Oncologists in public 🏥 are less likely to assess, refer or guide pts on exercise due to limited resources&training
See you there! #ASCO25
@crisbergerot @fitaftercancer @GlopesMd @EnriqueSoto8 @NarjustFlorezMD
Twice in the same week, sharing the stage with the stellar @ReginaBarCar !
Now in a different county (🇨🇴) and language (🇪🇸)!!! 🤣
It was a pleasure to participate in this very important initiative by @RPPGroup w/ such a stellar panel.
Prostate cancer screening in Brazil is still a challenging topic, but better tailored public policies certainly is the key to ensure an adequate approach for the adequate pts
Thanks to @RPPGroup for the opportunity to share insights on prostate cancer screening with @drdanielvargas, @heinvanpoppel, and @juliaismael4!
Putting it into perspective for 🇲🇽:
⏩Most frequent cancer in men
⏩Leading cause of cancer death
⏩45% diagnosed at metastatic stage
⏩Organized programs like @OpusIncanMX lead to earlier detection of clinically significant cases
@incanMX @smumexico @SMEOMX































